[Federal Register Volume 62, Number 243 (Thursday, December 18, 1997)]
[Pages 66372-66373]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-33035]



Office of the Secretary

Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.


SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) has made a final finding of scientific misconduct in the 
following case:
    S. Ashraf Imam, Ph.D., University of Southern California: Based on 
an investigation report forwarded to the Office of Research Integrity 
(ORI) by the University of Southern California (USC) as well as 
information obtained by ORI during its oversight review, ORI found that 
Dr. Imam, an Associate Professor in the Department of Pathology, USC, 
engaged in scientific misconduct by including plagiarized material in a 
grant application submitted to the National Cancer Institute (NCI), 
National Institutes of Health (NIH).
    Specifically, Dr. Imam's NIH grant application contained extensive 
paraphrasing of the text of another researcher's independent grant 
application to a state agency. Dr. Imam had been given that application 
by a colleague in confidence. The colleague was a reviewer on the state 
grant application and requested that Dr. Imam evaluate it and return 
the application to him.
    The other researcher's application was subsequently funded. Dr. 
Imam paraphrased or copied into his NIH application all of the other 
researcher's specific aims, the background on proposed methods, the 
experimental design and research plan, and most of the references; only 
the preliminary results sections of Dr. Imam's application were 
    Dr. Imam has accepted the ORI finding and has entered into a 
Voluntary Exclusion Agreement with ORI in which he has agreed, for the 
three (3) year period beginning December 8, 1997, to exclude himself 
voluntarily from:
    (1) any contracting or subcontracting with any agency of the United 
States Government and from eligibility for, or involvement in, 
nonprocurement transactions (e.g., grants and cooperative agreements) 
of the United States Government as defined in 45 CFR Part 76 (Debarment 
Regulations); and
    (2) serving in any advisory capacity to the Public Health Service 
(PHS), including but not limited to service on any PHS advisory 
committee, board, and/or peer review committee, or as a consultant.
    No scientific publications were required to be corrected as part of 
this Agreement.

FOR FURTHER INFORMATION CONTACT: Acting Director, Division of Research 
Investigations, Office of Research

[[Page 66373]]

Integrity, 5515 Security Lane, Suite 700, Rockville, MD 20852, (301) 
Chris B. Pascal, J.D.,
Acting Director, Office of Research Integrity.
[FR Doc. 97-33035 Filed 12-17-97; 8:45 am]